Julie Rosenberg

Learn More
PURPOSE Dasatinib is a potent BCR-ABL inhibitor with proven efficacy in adults with newly diagnosed chronic myeloid leukemia (CML) in chronic phase (CP) and in imatinib-resistant/intolerant disease. This phase I study of the Innovative Therapies for Children with Cancer Consortium assessed dasatinib safety and efficacy in pediatric patients. PATIENTS AND(More)
The Squire Self-rating Scale of Memory Function was administered to 28 depressed inpatients before and after electroconvulsive therapy (ECT), with random assignment to bilateral or unilateral electrode placement. Several memory changes differentiated between bilateral and unilateral ECT following treatment (p less than 0.05). Memory complaints arising from(More)
OBJECTIVE The purpose of this multicenter, open label, randomized phase III study was to determine whether ixabepilone resulted in improved overall survival (OS) compared with commonly used single-agent chemotherapy (doxorubicin or paclitaxel) in women with locally advanced, recurrent, or metastatic endometrial cancer with at least one failed prior(More)
A structured interview was used to elicit 35 depressed patients' reports of memory function after a full course of either bilateral or unilateral ECT. The interviewer and patients were blind to the type of electrode placement. Although the two groups of subjects did not differ in severity of depression or amount of ECT, significantly more patients receiving(More)
  • 1